Deciphera Pharmaceuticals Inc (DCPH.OQ)
DCPH.OQ on NASDAQ Stock Exchange Global Select Market
29.00USD
15 Feb 2019
29.00USD
15 Feb 2019
Change (% chg)
$1.03 (+3.68%)
$1.03 (+3.68%)
Prev Close
$27.97
$27.97
Open
$28.06
$28.06
Day's High
$29.03
$29.03
Day's Low
$27.72
$27.72
Volume
48,104
48,104
Avg. Vol
88,864
88,864
52-wk High
$45.61
$45.61
52-wk Low
$18.56
$18.56
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Sep '18 | 0.00 | -0.649 |
| Jun '18 | 0.00 | -0.646 | |
| Mar '18 | 0.00 | -0.657 | |
| FY 2017 | Dec '17 | 0.00 | -0.649 |
| Sep '17 | 0.00 | -0.392 | |
| Jun '17 | 0.00 | -0.346 | |
| Mar '17 | 0.00 | -0.251 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Mar-19 | 6 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Jun-19 | 6 | 0.00 | 0.00 | 0.00 | 0.00 |
| Year Ending Dec-19 | 10 | 10.00 | 100.00 | 0.00 | 18.75 |
| Earnings (per share) | |||||
| Quarter Ending Mar-19 | 4 | -0.80 | -0.70 | -0.87 | -0.61 |
| Quarter Ending Jun-19 | 4 | -0.84 | -0.76 | -0.92 | -0.63 |
| Year Ending Dec-19 | 10 | -2.90 | -0.29 | -3.67 | -2.48 |
| LT Growth Rate (%) | 1 | 21.00 | 21.00 | 21.00 | -- |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 69.44 | 33.70 | |
| P/E High - Last 5 Yrs. | -- | 147.79 | 49.87 | |
| P/E Low - Last 5 Yrs. | -- | 47.97 | 24.25 | |
| Beta | -- | 1.08 | 0.90 | |
| Price to Sales (TTM) | -- | 49.51 | 6.29 | |
| Price to Book (MRQ) | -- | 10.14 | 5.26 | |
| Price to Tangible Book (MRQ) | 8.04 | 13.78 | 6.77 | |
| Price to Cash Flow (TTM) | -- | 56.20 | 24.98 | |
| % Owned Institutions | -- | 3.74 | 1.69 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.12 | 1.40 | |
| Dividend Yield - 5 Year Avg | -- | 0.09 | 1.42 | |
| Dividend 5 Year Growth Rate | -- | 0.79 | 4.85 | |
| Payout Ratio(TTM) | -- | 7.02 | 41.03 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -- | 205.92 | 12.75 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -- | 48.79 | 5.84 | |
| Sales - 5 Yr. Growth Rate | -- | 22.76 | 11.23 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -79.11 | 75.85 | 47.15 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -- | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 11.98 | 10.85 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 9.07 | 15.20 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.24 | 2.25 |
| Current Ratio (MRQ) | 11.53 | 3.50 | 3.08 |
| LT Debt to Equity (MRQ) | 1.59 | 18.65 | 11.38 |
| Total Debt to Equity (MRQ) | 1.80 | 31.33 | 16.12 |
| Interest Coverage (TTM) | -- | -43.11 | 29.47 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 56.24 | 53.81 | |
| Gross Margin - 5 Yr. Avg. | -- | 60.48 | 52.18 | |
| EBITD Margin (TTM) | -- | -- | -- | |
| EBITD - 5 Yr. Avg | -- | -110.45 | 12.86 | |
| Operating Margin (TTM) | -- | -184.67 | 6.20 | |
| Operating Margin - 5 Yr. Avg. | -- | -126.94 | 8.31 | |
| Pre-Tax Margin (TTM) | -- | -175.36 | 7.16 | |
| Pre-Tax Margin - 5 Yr. Avg. | -- | -132.73 | 8.61 | |
| Net Profit Margin (TTM) | -- | -182.07 | 3.29 | |
| Net Profit Margin - 5 Yr. Avg. | -- | -137.12 | 4.89 | |
| Effective Tax Rate (TTM) | -- | 22.48 | 22.91 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 15.51 | 23.38 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | -- | 7,654,354 | 842,397,297 | |
| Net Income/Employee (TTM) | -- | 562,076 | 99,842,671 | |
| Receivable Turnover (TTM) | -- | 6.23 | 5.71 | |
| Inventory Turnover (TTM) | -- | 1.89 | 3.47 | |
| Asset Turnover (TTM) | -- | 0.32 | 0.93 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -- | 6.39 | 11.06 | |
| Return on Assets - 5 Yr. Avg. | -- | 5.47 | 12.20 | |
| Return on Investment (TTM) | -- | 8.92 | 14.45 | |
| Return on Investment - 5 Yr. Avg. | -- | 6.78 | 15.87 | |
| Return on Equity (TTM) | -- | 10.08 | 15.96 | |
| Return on Equity - 5 Yr. Avg. | -- | 8.32 | 17.00 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -- | -- | -- |
| EPS (TTM) % | -30.90 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Deciphera Pharmaceuticals Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | -- | -- | -- | 99 |
| 13 Week | -- | -- | -- | 95 |
| 26 Week | -- | -- | -- | 98 |
| 52 Week | -- | -- | -- | 72 |
| YTD | -- | -- | -- | 72 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 58.57% |
| # of Holders: | 113 |
| Total Shares Held: | 22,059,929 |
| 3 Mo. Net Change: | 935,332 |
| # New Positions: | 18 |
| # Closed Positions: | 28 |
| # Increased Positions: | 61 |
| # Reduced Positions: | 50 |
| # Net Buyers: | 11 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.